BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37996388)

  • 21. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
    He H; Du L; Xue H; Wu J; Shuai X
    Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Glutathione Activatable Photosensitizer for Combined Photodynamic and Gas Therapy under Red Light Irradiation.
    Wang R; Xia X; Yang Y; Rong X; Liu T; Su Z; Zeng X; Du J; Fan J; Sun W; Peng X
    Adv Healthc Mater; 2022 Feb; 11(4):e2102017. PubMed ID: 34812594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photosynthetic Tumor Oxygenation by Photosensitizer-Containing Cyanobacteria for Enhanced Photodynamic Therapy.
    Huo M; Wang L; Zhang L; Wei C; Chen Y; Shi J
    Angew Chem Int Ed Engl; 2020 Jan; 59(5):1906-1913. PubMed ID: 31721383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From Low to No O
    Li M; Xu Y; Peng X; Kim JS
    Acc Chem Res; 2022 Nov; 55(22):3253-3264. PubMed ID: 36323625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cu
    Su Z; Xu H; Zhang H; Jin S; Yang Z; Yan R; Wang Z; Wu X; Jin Y
    Bioconjug Chem; 2023 Jul; 34(7):1336-1347. PubMed ID: 37343132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activatable Type I Photosensitizer with Quenched Photosensitization Pre and Post Photodynamic Therapy.
    Tian J; Li B; Zhang F; Yao Z; Song W; Tang Y; Ping Y; Liu B
    Angew Chem Int Ed Engl; 2023 Nov; 62(46):e202307288. PubMed ID: 37681940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advances in AIEgen-Based Photodynamic Therapy and Immunotherapy.
    Zha M; Yang G; Li Y; Zhang C; Li B; Li K
    Adv Healthc Mater; 2021 Dec; 10(24):e2101066. PubMed ID: 34519181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light-responsive smart nanocarriers for wirelessly controlled photodynamic therapy for prostate cancers.
    Sun B; Liu J; Kim HJ; Rahmat JNB; Neoh KG; Zhang Y
    Acta Biomater; 2023 Nov; 171():553-564. PubMed ID: 37739246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy.
    Li X; Kwon N; Guo T; Liu Z; Yoon J
    Angew Chem Int Ed Engl; 2018 Sep; 57(36):11522-11531. PubMed ID: 29808948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unleashing the power of porphyrin photosensitizers: Illuminating breakthroughs in photodynamic therapy.
    Akbar A; Khan S; Chatterjee T; Ghosh M
    J Photochem Photobiol B; 2023 Nov; 248():112796. PubMed ID: 37804542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy.
    Yu H; Chen B; Huang H; He Z; Sun J; Wang G; Gu X; Tang BZ
    Biosensors (Basel); 2022 May; 12(5):. PubMed ID: 35624649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy.
    Pham TC; Nguyen VN; Choi Y; Lee S; Yoon J
    Chem Rev; 2021 Nov; 121(21):13454-13619. PubMed ID: 34582186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-photosensitizers for enhanced photodynamic therapy.
    Lin L; Song X; Dong X; Li B
    Photodiagnosis Photodyn Ther; 2021 Dec; 36():102597. PubMed ID: 34699982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Cell-Responsive Photodynamic Immunoagent for Immunogenicity-Enhanced Orthotopic and Remote Tumor Therapy.
    Chen Y; Xiong T; Zhao X; Du J; Sun W; Fan J; Peng X
    Adv Healthc Mater; 2023 Feb; 12(5):e2202085. PubMed ID: 36377488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy.
    Luo Y; Zeng Z; Shan T; Xu X; Chen J; He Y; Zhang T; Huang Z; Chai G; Huang Y; Zhao Y; Zhao C
    Theranostics; 2022; 12(8):3610-3627. PubMed ID: 35664057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in strategies for overcoming hypoxia in photodynamic therapy of cancer.
    Pucelik B; Sułek A; Barzowska A; Dąbrowski JM
    Cancer Lett; 2020 Nov; 492():116-135. PubMed ID: 32693200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
    Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
    Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumors.
    Sun R; Ma W; Ling M; Tang C; Zhong M; Dai J; Zhu M; Cai X; Li G; Xu Q; Tang L; Yu Z; Peng Z
    J Control Release; 2022 Oct; 350():525-537. PubMed ID: 36055597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable NIR-II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor-Associated Macrophage Reprogramming.
    Wan J; Zhang X; Tang D; Liu T; Xiao H
    Adv Mater; 2023 Aug; 35(31):e2209799. PubMed ID: 37276889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-situ bio-assembled specific Au NCs-Aptamer-Pyro conjugates nanoprobe for tumor imaging and mitochondria-targeted photodynamic therapy.
    Xiong H; Ye J; Wang M; Wang Y; Liu X; Jiang H; Wang X
    Biosens Bioelectron; 2022 Dec; 218():114763. PubMed ID: 36240628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.